Drugs / Ceftazidim
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02463747 | Jun 2015 → Jun 2017 | neutropenia | Tel-Aviv Sourasky Medical Center | Unknown | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ceftazidim | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02463747 ↗ |
| Route | Intravenous | “Ceftazidim): 2.0gr, TID, I.V.” NCT02463747 ↗ |